Cargando…

Down-regulation of Lsm1 is involved in human prostate cancer progression

Elucidation of genetic alterations is an approach to understanding the underlying molecular mechanisms of progression of human prostate cancers. We have searched for genes differentially expressed in advanced prostate cancers using cDNA-representational difference analysis, and thereby isolated the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takahashi, S, Suzuki, S, Inaguma, S, Cho, Y-M, Ikeda, Y, Hayashi, N, Inoue, T, Sugimura, Y, Nishiyama, N, Fujita, T, Ushijima, T, Shirai, T
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2002
Materias:	Genetics and Genomics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364150/ https://www.ncbi.nlm.nih.gov/pubmed/11953827 http://dx.doi.org/10.1038/sj.bjc.6600163

Ejemplares similares

Genetic analysis of multifocal superficial urothelial cancers by array-based comparative genomic hybridisation
por: Kawanishi, H, et al.
Publicado: (2007)

Differential gene expression profiles of gastric cancer cells established from primary tumour and malignant ascites
por: Sakakura, C, et al.
Publicado: (2002)

Tumour suppressors miR-1 and miR-133a target the oncogenic function of purine nucleoside phosphorylase (PNP) in prostate cancer
por: Kojima, S, et al.
Publicado: (2012)

Genetic and epigenetic alterations on the short arm of chromosome 11 are involved in a majority of sporadic Wilms' tumours
por: Satoh, Y, et al.
Publicado: (2006)

Role of genetic polymorphisms of the RNASEL gene on familial prostate cancer risk in a Japanese population
por: Nakazato, H, et al.
Publicado: (2003)

B-RAF mutation and accumulated gene methylation in aberrant crypt foci (ACF), sessile serrated adenoma/polyp (SSA/P) and cancer in SSA/P
por: Inoue, A, et al.
Publicado: (2015)

Crystal Structures of Lsm3, Lsm4 and Lsm5/6/7 from Schizosaccharomyces pombe
por: Wu, Donghui, et al.
Publicado: (2012)

LY6K is a novel molecular target in bladder cancer on basis of integrate genome-wide profiling
por: Matsuda, R, et al.
Publicado: (2011)

Splice variant PRKC-ζ(-PrC) is a novel biomarker of human prostate cancer
por: Yao, S, et al.
Publicado: (2012)

Clinical Significance and Potential Role of LSM4 Overexpression in Hepatocellular Carcinoma: An Integrated Analysis Based on Multiple Databases
por: Chen, Liang, et al.
Publicado: (2022)

Polymorphism of the insulin gene is associated with increased prostate cancer risk
por: Ho, G Y F, et al.
Publicado: (2003)

Analysis of Lsm1p and Lsm8p domains in the cellular localization of Lsm complexes in budding yeast
por: Reijns, Martin A M, et al.
Publicado: (2009)

Lsm2 and Lsm3 bridge the interaction of the Lsm1-7 complex with Pat1 for decapping activation
por: Wu, Donghui, et al.
Publicado: (2014)

Genetic and epigenetic alterations of Ras signalling pathway in colorectal neoplasia: analysis based on tumour clinicopathological features
por: Harada, K, et al.
Publicado: (2007)

CYP3A4 and VDR gene polymorphisms and the risk of prostate cancer in men with benign prostate hyperplasia
por: Tayeb, M T, et al.
Publicado: (2003)

Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
por: Edwards, S M, et al.
Publicado: (2010)

Multifunctional transcription factor TFII-I is an activator of BRCA1 function
por: Tanikawa, M, et al.
Publicado: (2011)

Frequent epigenetic inactivation of Wnt antagonist genes in breast cancer
por: Suzuki, H, et al.
Publicado: (2008)

Analysis of gene alterations of mitochondrial DNA D-loop regions to determine breast cancer clonality
por: Masuda, S, et al.
Publicado: (2012)

Prostate cancer in male BRCA1 and BRCA2 mutation carriers has a more aggressive phenotype
por: Mitra, A, et al.
Publicado: (2008)

Impaired expression of protein phosphatase 2A subunits enhances metastatic potential of human prostate cancer cells through activation of AKT pathway
por: Pandey, P, et al.
Publicado: (2013)

A non-mosaic transchromosomic mouse model of Down syndrome carrying the long arm of human chromosome 21
por: Kazuki, Yasuhiro, et al.
Publicado: (2020)

CHEK2 variants associate with hereditary prostate cancer
por: Seppälä, E H, et al.
Publicado: (2003)

Expression of the TMPRSS2:ERG fusion gene predicts cancer recurrence after surgery for localised prostate cancer
por: Nam, R K, et al.
Publicado: (2007)

Genetic architecture of prostate cancer in the Ashkenazi Jewish population
por: Vijai, J, et al.
Publicado: (2011)

Molecular diagnosis of primary liver cancer by microsatellite DNA analysis in the serum
por: Chang, Y-C, et al.
Publicado: (2002)

High frequency of mitochondrial genome instability in human endometrial carcinomas
por: Liu, V W S, et al.
Publicado: (2003)

miR-320c regulates gemcitabine-resistance in pancreatic cancer via SMARCC1
por: Iwagami, Y, et al.
Publicado: (2013)

Polygenic susceptibility to prostate and breast cancer: implications for personalised screening
por: Pashayan, N, et al.
Publicado: (2011)

Epigenetic inactivation of TCF2 in ovarian cancer and various cancer cell lines
por: Terasawa, K, et al.
Publicado: (2006)

Possible alternative carcinogenesis pathway featuring microsatellite instability in colorectal cancer stroma
por: Matsumoto, N, et al.
Publicado: (2003)

BRCA2 is a moderate penetrance gene contributing to young-onset prostate cancer: implications for genetic testing in prostate cancer patients
por: Kote-Jarai, Z, et al.
Publicado: (2011)

The relationship between aberrant methylation and survival in non-small-cell lung cancers
por: Toyooka, S, et al.
Publicado: (2004)

Frequent allelic deletion at the FHIT locus associated with p53 overexpression in squamous cell carcinoma subtype of Taiwanese non-small-cell lung cancers
por: Lee, Y-C, et al.
Publicado: (2004)

Transcriptional profiling of Epstein–Barr virus (EBV) genes and host cellular genes in nasal NK/T-cell lymphoma and chronic active EBV infection
por: Zhang, Y, et al.
Publicado: (2006)

Regulatory potential for concerted modulation of Nrf2- and Nfkb1-mediated gene expression in inflammation and carcinogenesis
por: Nair, S, et al.
Publicado: (2008)

ATM polymorphisms as risk factors for prostate cancer development
por: Angèle, S, et al.
Publicado: (2004)

Germline BRCA1 mutations increase prostate cancer risk
por: Leongamornlert, D, et al.
Publicado: (2012)

Roles of Fhit and p53 in Taiwanese surgically treated non-small-cell lung cancers
por: Chang, Y-L, et al.
Publicado: (2003)

A mechanism of resistance to TRAIL/Apo2L-induced apoptosis of newly established glioma cell line and sensitisation to TRAIL by genotoxic agents
por: Arizono, Y, et al.
Publicado: (2003)

Cannot write session to /tmp/vufind_sessions/sess_ikc6b9mqoldaqejbggs8jhbpip